EP3749671 - [1,2,4]TRIAZOLO[4,3-A]PYRAZIN-8-ONE DERIVATIVES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 02.02.2024 Database last updated on 24.08.2024 | |
Former | The patent has been granted Status updated on 24.02.2023 | ||
Former | Grant of patent is intended Status updated on 19.10.2022 | ||
Former | Examination is in progress Status updated on 15.10.2021 | ||
Former | Request for examination was made Status updated on 13.11.2020 | ||
Former | The international publication has been made Status updated on 17.08.2019 | ||
Former | unknown Status updated on 11.03.2019 | Most recent event Tooltip | 17.05.2024 | Lapse of the patent in a contracting state New state(s): SI | published on 19.06.2024 [2024/25] | Applicant(s) | For all designated states Eli Lilly and Company Lilly Corporate Center Indianapolis, IN 46285 / US | [2023/13] |
Former [2020/51] | For all designated states Eli Lilly and Company Lilly Corporate Center Indianapolis, IN 46285 / US | Inventor(s) | 01 /
CAMP, Nicholas Paul c/o ELI LILLY AND COMPANY P.O. Box 6288 Indianapolis, Indiana 46206-6288 / US | 02 /
HAMDOUCHI, Chafiq c/o ELI LILLY AND COMPANY P.O. Box 6288 Indianapolis, Indiana 46206-6288 / US | 03 /
LINESWALA, Jayana Pankaj c/o ELI LILLY AND COMPANY P.O. Box 6288 Indianapolis, Indiana 46206-6288 / US | 04 /
MORPHY, John Richard c/o ELI LILLY AND COMPANY P.O. Box 6288 Indianapolis, Indiana 46206-6288 / US | 05 /
SHI, Qing c/o ELI LILLY AND COMPANY P.O. Box 6288 Indianapolis, Indiana 46206-6288 / US | [2020/51] | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [2023/13] |
Former [2020/51] | Ingham, Stephen Howard Eli Lilly and Company Limited 8 Arlington Square West Downshire Way Bracknell, Berkshire RG12 1PU / GB | Application number, filing date | 19707923.9 | 30.01.2019 | [2020/51] | WO2019US15757 | Priority number, date | US201862626745P | 06.02.2018 Original published format: US 201862626745 P | [2020/51] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019156861 | Date: | 15.08.2019 | Language: | EN | [2019/33] | Type: | A1 Application with search report | No.: | EP3749671 | Date: | 16.12.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 15.08.2019 takes the place of the publication of the European patent application. | [2020/51] | Type: | B1 Patent specification | No.: | EP3749671 | Date: | 29.03.2023 | Language: | EN | [2023/13] | Search report(s) | International search report - published on: | EP | 15.08.2019 | Classification | IPC: | C07D487/04, A61P13/12, A61K31/4985 | [2020/51] | CPC: |
C07D487/04 (EP,US);
A61P13/12 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/51] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | [1,2,4]TRIAZOLO[4,3-A]PYRAZIN-8-ON-DERIVATE | [2020/51] | English: | [1,2,4]TRIAZOLO[4,3-A]PYRAZIN-8-ONE DERIVATIVES | [2020/51] | French: | DÉRIVÉS DE [1,2,4]TRIAZOLO[4,3-A]PYRAZIN-8-ONE | [2020/51] | Entry into regional phase | 07.09.2020 | National basic fee paid | 07.09.2020 | Designation fee(s) paid | 07.09.2020 | Examination fee paid | Examination procedure | 04.09.2020 | Amendment by applicant (claims and/or description) | 07.09.2020 | Examination requested [2020/51] | 07.09.2020 | Date on which the examining division has become responsible | 19.10.2021 | Despatch of a communication from the examining division (Time limit: M06) | 11.04.2022 | Reply to a communication from the examining division | 19.10.2022 | Communication of intention to grant the patent | 14.02.2023 | Fee for grant paid | 14.02.2023 | Fee for publishing/printing paid | 14.02.2023 | Receipt of the translation of the claim(s) | Opposition(s) | 03.01.2024 | No opposition filed within time limit [2024/10] | Fees paid | Renewal fee | 01.02.2021 | Renewal fee patent year 03 | 04.01.2022 | Renewal fee patent year 04 | 03.01.2023 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 29.03.2023 | CZ | 29.03.2023 | DK | 29.03.2023 | EE | 29.03.2023 | FI | 29.03.2023 | HR | 29.03.2023 | LT | 29.03.2023 | LV | 29.03.2023 | PL | 29.03.2023 | RO | 29.03.2023 | RS | 29.03.2023 | SE | 29.03.2023 | SI | 29.03.2023 | SK | 29.03.2023 | SM | 29.03.2023 | NO | 29.06.2023 | IS | 29.07.2023 | PT | 31.07.2023 | [2024/25] |
Former [2024/10] | AT | 29.03.2023 | |
CZ | 29.03.2023 | ||
DK | 29.03.2023 | ||
EE | 29.03.2023 | ||
FI | 29.03.2023 | ||
HR | 29.03.2023 | ||
LT | 29.03.2023 | ||
LV | 29.03.2023 | ||
PL | 29.03.2023 | ||
RO | 29.03.2023 | ||
RS | 29.03.2023 | ||
SE | 29.03.2023 | ||
SK | 29.03.2023 | ||
SM | 29.03.2023 | ||
NO | 29.06.2023 | ||
IS | 29.07.2023 | ||
PT | 31.07.2023 | ||
Former [2023/50] | AT | 29.03.2023 | |
EE | 29.03.2023 | ||
FI | 29.03.2023 | ||
HR | 29.03.2023 | ||
LT | 29.03.2023 | ||
LV | 29.03.2023 | ||
PL | 29.03.2023 | ||
RO | 29.03.2023 | ||
RS | 29.03.2023 | ||
SE | 29.03.2023 | ||
SK | 29.03.2023 | ||
SM | 29.03.2023 | ||
NO | 29.06.2023 | ||
IS | 29.07.2023 | ||
PT | 31.07.2023 | ||
Former [2023/49] | AT | 29.03.2023 | |
EE | 29.03.2023 | ||
FI | 29.03.2023 | ||
HR | 29.03.2023 | ||
LT | 29.03.2023 | ||
LV | 29.03.2023 | ||
RO | 29.03.2023 | ||
RS | 29.03.2023 | ||
SE | 29.03.2023 | ||
SM | 29.03.2023 | ||
NO | 29.06.2023 | ||
PT | 31.07.2023 | ||
Former [2023/48] | AT | 29.03.2023 | |
EE | 29.03.2023 | ||
FI | 29.03.2023 | ||
HR | 29.03.2023 | ||
LT | 29.03.2023 | ||
LV | 29.03.2023 | ||
RS | 29.03.2023 | ||
SE | 29.03.2023 | ||
SM | 29.03.2023 | ||
NO | 29.06.2023 | ||
PT | 31.07.2023 | ||
Former [2023/46] | FI | 29.03.2023 | |
HR | 29.03.2023 | ||
LT | 29.03.2023 | ||
LV | 29.03.2023 | ||
RS | 29.03.2023 | ||
SE | 29.03.2023 | ||
SM | 29.03.2023 | ||
NO | 29.06.2023 | ||
PT | 31.07.2023 | ||
Former [2023/36] | FI | 29.03.2023 | |
HR | 29.03.2023 | ||
LT | 29.03.2023 | ||
LV | 29.03.2023 | ||
RS | 29.03.2023 | ||
SE | 29.03.2023 | ||
NO | 29.06.2023 | ||
Former [2023/35] | HR | 29.03.2023 | |
LT | 29.03.2023 | ||
RS | 29.03.2023 | ||
NO | 29.06.2023 | ||
Former [2023/34] | LT | 29.03.2023 | |
RS | 29.03.2023 | ||
Former [2023/33] | LT | 29.03.2023 | Cited in | International search | [YD]WO2016055618 (LUNDBECK & CO AS H [DK]) [YD] 1-15 * Whole document, particularly claims 1 and examples 6, 7, 30 and 79-84; pages 1-3 *; | [YD]WO2017139186 (LILLY CO ELI [US]) [YD] 1-15* Whole document, particularly clam 1, and Tables 1-3 * | by applicant | WO2016055618 | US2017233396 | - GOULD, P.L., "Salt selection for basic drugs", International Journal of Pharmaceutics, (19860000), vol. 33, doi:doi:10.1016/0378-5173(86)90055-4, pages 201 - 217, XP025813036 DOI: http://dx.doi.org/10.1016/0378-5173(86)90055-4 | - BASTIN, R.J. et al., "Salt Selection and Optimization Procedures for Pharmaceutical New Chemical Entities", Organic Process Research and Development, (20000000), vol. 4, pages 427 - 43 5 | - BERGE, S.M. et al., "Pharmaceutical Salts", Journal of Pharmaceutical Sciences, (19770000), vol. 66, doi:doi:10.1002/jps.2600660104, pages 1 - 19, XP002675560 DOI: http://dx.doi.org/10.1002/jps.2600660104 |